Loading…
Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis
In this article, we report a series of benzaldehyde thiosemicarbazone derivatives possessing high activity toward actively replicating Mycobacterium tuberculosis strain with minimum inhibitory concentration (MIC) values in the range from 0.14 to 2.2 μM. Among them, two compounds—2-(4-phenethoxybenzy...
Saved in:
Published in: | Journal of antibiotics 2019-04, Vol.72 (4), p.218-224 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this article, we report a series of benzaldehyde thiosemicarbazone derivatives possessing high activity toward actively replicating
Mycobacterium tuberculosis
strain with minimum inhibitory concentration (MIC) values in the range from 0.14 to 2.2 μM. Among them, two compounds—2-(4-phenethoxybenzylidene)hydrazine-1-carbothioamide (
13
) and 2-(3-isopropoxybenzylidene)hydrazine-1-carbothioamide (
20
) also demonstrate submicromolar antimycobacterial activity against
M. tuberculosis
under hypoxia with MIC values of 0.68 and 0.74 μM, respectively. The activity of compounds
13
and
20
toward five investigated isoniazid-, rifampicin-, and fluoroquinolone-resistant
M. tuberculosis
isolates is similar to commercially available antituberculosis drugs. The compounds
13
and
20
possess good ADME properties and have low cytotoxicity toward human liver cells (HepG2). Therefore, 2-(4-phenethoxybenzylidene)hydrazine-1-carbothioamide (
13
) and 2-(3-isopropoxybenzylidene)hydrazine-1-carbothioamide (
20
) are valuable candidates for further preclinical studies. |
---|---|
ISSN: | 0021-8820 1881-1469 |
DOI: | 10.1038/s41429-019-0140-9 |